论文信息 - A case of severe hypothyroidism due to lenalidomide

A case of severe hypothyroidism due to lenalidomide

Lenalidomide, an immunomodulatory drug often used to treat multiple myeloma, can cause hypo‐ or hyperthyroidism. We present a patient being treated with lenalidomide for 2 years who developed severe hypothyroidism that was complicated by rhabdomyolysis and acute kidney injury. Thyroid function tests should be serially monitored in patients taking lenalidomide.

D. Leaf | Rachel A. Blair | R. K. Leaf | Rachel A Blair

[1] I. Munir,et al. Rhabdomyolysis in a Patient with Severe Hypothyroidism , 2017, The American journal of case reports.

[2] M. Ermani,et al. Lenalidomide long-term neurotoxicity , 2016, Neurology.

[3] S. Karasawa,et al. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide , 2012, Leukemia.

[4] P. Larsen,et al. Thyroid dysfunction from antineoplastic agents. , 2011, Journal of the National Cancer Institute.

[5] A. Kassim,et al. Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: Results of a retrospective case review , 2011, American journal of hematology.

[6] Joseph Varon,et al. Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians , 2004, Critical care.

[7] A. Wägner,et al. Hypothyroidism as a cause of rhabdomyolysis. , 2002, Endocrine journal.

[8] L. Murri,et al. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. , 1997, The Journal of clinical endocrinology and metabolism.

[9] D. Jones,et al. Muscle relaxation rate, fibre-type composition and energy turnover in hyper- and hypo-thyroid patients. , 1979, Clinical science.